Global Rapid Drug Screen Market Growth 2025-2031
The global Rapid Drug Screen market size is predicted to grow from US$ 7254 million in 2025 to US$ 14990 million in 2031; it is expected to grow at a CAGR of 12.9% from 2025 to 2031.
Drug screening is a technique for detecting illegal substances in saliva, sperm, and other biological samples. During this process, potential drugs are identified and engineered to proceed to clinical trials until a candidate product is selected. This includes scanning large chemical collections for a specific biological operation in high-throughput screening assays.
Drug abuse and alcohol consumption are increasing worldwide. Rising prevalence of opioid overdose is expected to drive market growth over the forecast period. For example, opioids include compounds extracted from poppy seeds, as well as synthetic and semi-synthetic compounds with similar properties that can interact with opioid receptors in the brain, according to data released by the World Health Organization in 2021. According to the same source, approximately 275 million people worldwide (5.5% of the global population aged 15-64) have used drugs at least once. Of these, about 62 million people use opioids. Alcohol consumption has also seen a similar rise, with the consequence of rising incidences of impaired driving, rising consumption of illicit drugs and alcohol will further boost the development of drug screening products and services.
LP Information, Inc. (LPI) ' newest research report, the ?Rapid Drug Screen Industry Forecast? looks at past sales and reviews total world Rapid Drug Screen sales in 2024, providing a comprehensive analysis by region and market sector of projected Rapid Drug Screen sales for 2025 through 2031. With Rapid Drug Screen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Drug Screen industry.
This Insight Report provides a comprehensive analysis of the global Rapid Drug Screen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Drug Screen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Rapid Drug Screen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Drug Screen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Drug Screen.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Drug Screen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Saliva Detection
Urine Examination
Sperm Test
Segmentation by Application:
Judicial Office
Hospital
Drug Treatment Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Thermo fisher Scientific Inc
Premier Biotech, Inc.
LabCorp
Quest Diagnostics
Dr?gerwerk AG&Co. KGaA
Siemens Healthineers
Quest Diagnostics Incorporated
Alfa Scientific Designs?Inc
Lifeloc Technologies Inc
OraSure Technologies?Inc
Omega Laboratories?Inc
Shimadzu Corporation
F. Hoffmann-La Roche Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rapid Drug Screen market?
What factors are driving Rapid Drug Screen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rapid Drug Screen market opportunities vary by end market size?
How does Rapid Drug Screen break out by Type, by Application?
Drug screening is a technique for detecting illegal substances in saliva, sperm, and other biological samples. During this process, potential drugs are identified and engineered to proceed to clinical trials until a candidate product is selected. This includes scanning large chemical collections for a specific biological operation in high-throughput screening assays.
Drug abuse and alcohol consumption are increasing worldwide. Rising prevalence of opioid overdose is expected to drive market growth over the forecast period. For example, opioids include compounds extracted from poppy seeds, as well as synthetic and semi-synthetic compounds with similar properties that can interact with opioid receptors in the brain, according to data released by the World Health Organization in 2021. According to the same source, approximately 275 million people worldwide (5.5% of the global population aged 15-64) have used drugs at least once. Of these, about 62 million people use opioids. Alcohol consumption has also seen a similar rise, with the consequence of rising incidences of impaired driving, rising consumption of illicit drugs and alcohol will further boost the development of drug screening products and services.
LP Information, Inc. (LPI) ' newest research report, the ?Rapid Drug Screen Industry Forecast? looks at past sales and reviews total world Rapid Drug Screen sales in 2024, providing a comprehensive analysis by region and market sector of projected Rapid Drug Screen sales for 2025 through 2031. With Rapid Drug Screen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Drug Screen industry.
This Insight Report provides a comprehensive analysis of the global Rapid Drug Screen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Drug Screen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Rapid Drug Screen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Drug Screen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Drug Screen.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Drug Screen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Saliva Detection
Urine Examination
Sperm Test
Segmentation by Application:
Judicial Office
Hospital
Drug Treatment Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Thermo fisher Scientific Inc
Premier Biotech, Inc.
LabCorp
Quest Diagnostics
Dr?gerwerk AG&Co. KGaA
Siemens Healthineers
Quest Diagnostics Incorporated
Alfa Scientific Designs?Inc
Lifeloc Technologies Inc
OraSure Technologies?Inc
Omega Laboratories?Inc
Shimadzu Corporation
F. Hoffmann-La Roche Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rapid Drug Screen market?
What factors are driving Rapid Drug Screen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rapid Drug Screen market opportunities vary by end market size?
How does Rapid Drug Screen break out by Type, by Application?
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
